Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Bristol-Myers Squibb and Simcere to jointly develop BMS-817378

Nov. 8, 2010

Oncothyreon begins phase I/II trial of PX-866/docetaxel combination

Nov. 5, 2010

Adventrx Pharma submits NDA to FDA for vinorelbine

Nov. 5, 2010

Takeda and Millennium initiate phase III TAK-700 program in prostate cancer

Nov. 5, 2010

New progesterone receptor antagonists presented by Evestra

Nov. 5, 2010

Interim phase I/II data presented on dovitinib in RCC

Nov. 5, 2010

Preliminary phase II/III data disclosed on fosbretabulin plus chemotherapy in ATC

Nov. 5, 2010

MLN-8237 shows promise in epithelial ovarian, fallopian tube and primary peritoneal carcinoma

Nov. 5, 2010

Gynecologic Oncology Group to begin phase II elesclomol trial in ovarian cancer

Nov. 4, 2010

Viralytics submits IND for phase II trial of Cavatak in melanoma

Nov. 4, 2010

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...